Elevance Health stock trades at 377.45 euros after fresh update
Published on 11/04/2026 at 16:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSFresh trading update for investors
- Elevance Health stock moved materially above the quote cited in the latest report.
- The insurer remains a focus for investors tracking health-plan margins and membership trends.
Elevance Health stock traded at 377.45 euros on Lang & Schwarz at 16:37 CET on Wednesday, November 4, 2026. The quote was 2.65 percent above the 367.70-euro indication cited in the previous report from earlier the same day.
Trading momentum remains in focus
The move gives investors a fresh reference point for the US health insurer's European trading indication. It also keeps attention on how the stock develops after the latest analyst target revisions and the company's recent quarterly update.
For investors, the next signals include health-plan margins, membership trends and the earnings outlook. These factors remain central to assessing whether the recent trading momentum can persist.
See the real-time quote of Elevance Health stock for the latest indication.
The S&P 500 provides the broader market context for US-listed healthcare stocks: current market reports.
For further developments, see more news and analyses on Elevance Health stock.
Elevance Health stock snapshot
- Company: Elevance Health
- ISIN: US0367521038
- Trading venue: Lang & Schwarz
- Quote: 377.45 euros at 16:37 CET on November 4, 2026
- Change since prior report: 2.65 percent above 367.70 euros cited at 13:36 CET on November 4, 2026
